A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome.
There is currently no approved treatment for primary Sjögren's syndrome, a disease that primarily affects adult women. The difficulty in developing effective therapies is -in part- because of the heterogeneity in the clinical manifestation and pathophysiology of the disease. Finding common mole...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2021
|
| Sorozat: | NATURE COMMUNICATIONS
12 No. 1 |
| doi: | 10.1038/s41467-021-23472-7 |
| mtmt: | 32070528 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/21663 |